Then, we conducted single-cell RNA sequencing (scRNA-seq), RNA sequencing, western blot, and immunofluorescence to provide more useful data and information for further investigating the molecular pathogenetic mechanisms of muscular dystrophy and brain dysfunction for LAMA2-CMD. The gene discussed is LAMA2; the disease is congenital muscular dystrophy.